BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2831042)

  • 1. Fabry disease: molecular diagnosis of hemizygotes and heterozygotes.
    Desnick RJ; Bernstein HS; Astrin KH; Bishop DF
    Enzyme; 1987; 38(1-4):54-64. PubMed ID: 2831042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes.
    Ashton-Prolla P; Tong B; Shabbeer J; Astrin KH; Eng CM; Desnick RJ
    J Investig Med; 2000 Jul; 48(4):227-35. PubMed ID: 10916280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabry disease: molecular genetics of the inherited nephropathy.
    Desnick RJ; Astrin KH; Bishop DF
    Adv Nephrol Necker Hosp; 1989; 18():113-27. PubMed ID: 2564247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene.
    Bernstein HS; Bishop DF; Astrin KH; Kornreich R; Eng CM; Sakuraba H; Desnick RJ
    J Clin Invest; 1989 Apr; 83(4):1390-9. PubMed ID: 2539398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone.
    Kirkilionis AJ; Riddell DC; Spence MW; Fenwick RG
    J Med Genet; 1991 Apr; 28(4):232-40. PubMed ID: 1677424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-galactosidase A gene rearrangements causing Fabry disease. Identification of short direct repeats at breakpoints in an Alu-rich gene.
    Kornreich R; Bishop DF; Desnick RJ
    J Biol Chem; 1990 Jun; 265(16):9319-26. PubMed ID: 2160973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of human polymorphic sites in the X-chromosomal region q21.33 to q24: DXS17, DXS87, DXS287, and alpha-galactosidase A.
    Kornreich R; Astrin KH; Desnick RJ
    Genomics; 1992 May; 13(1):70-4. PubMed ID: 1349583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fabry disease: molecular carrier detection and prenatal diagnosis by analysis of closely linked polymorphisms at Xq22.1.
    Caggana M; Ashley GA; Desnick RJ; Eng CM
    Am J Med Genet; 1997 Aug; 71(3):329-35. PubMed ID: 9268104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular genetics of inherited metabolic diseases--its application to the investigation of pathogenesis and the diagnosis of Fabry disease].
    Sakuraba H
    Rinsho Byori; 1994 Jun; 42(6):628-35. PubMed ID: 7914243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anderson Fabry disease, a close linkage with highly polymorphic DNA markers DXS17, DXS87 and DXS88.
    MacDermot KD; Morgan SH; Cheshire JK; Wilson TM
    Hum Genet; 1987 Nov; 77(3):263-6. PubMed ID: 2890570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabry disease: detection of gene rearrangements in the human alpha-galactosidase A gene by multiplex PCR amplification.
    Kornreich R; Desnick RJ
    Hum Mutat; 1993; 2(2):108-11. PubMed ID: 8318986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene.
    Eng CM; Desnick RJ
    Hum Mutat; 1994; 3(2):103-11. PubMed ID: 7911050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature and frequency of mutations in the alpha-galactosidase A gene that cause Fabry disease.
    Eng CM; Resnick-Silverman LA; Niehaus DJ; Astrin KH; Desnick RJ
    Am J Hum Genet; 1993 Dec; 53(6):1186-97. PubMed ID: 7504405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.
    Germain DP; Poenaru L
    Biochem Biophys Res Commun; 1999 Apr; 257(3):708-13. PubMed ID: 10208848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabry disease: comparison of enzymatic, linkage, and mutation analysis for carrier detection in a family with a novel mutation (30delG).
    Ashton-Prolla P; Ashley GA; Giugliani R; Pires RF; Desnick RJ; Eng CM
    Am J Med Genet; 1999 Jun; 84(5):420-4. PubMed ID: 10360396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygote detection in Fabry disease utilizing multiple enzyme activities.
    Sheth KJ; Good TA; Murphy JV
    Am J Med Genet; 1981; 10(2):141-6. PubMed ID: 6274191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty novel mutations in the alpha-galactosidase A gene causing Fabry disease.
    Topaloglu AK; Ashley GA; Tong B; Shabbeer J; Astrin KH; Eng CM; Desnick RJ
    Mol Med; 1999 Dec; 5(12):806-11. PubMed ID: 10666480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabry disease: thirty-five mutations in the alpha-galactosidase A gene in patients with classic and variant phenotypes.
    Eng CM; Ashley GA; Burgert TS; Enriquez AL; D'Souza M; Desnick RJ
    Mol Med; 1997 Mar; 3(3):174-82. PubMed ID: 9100224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel alpha-galactosidase A mutation in a female with recurrent strokes.
    Tuttolomondo A; Duro G; Miceli S; Di Raimondo D; Pecoraro R; Serio A; Albeggiani G; Nuzzo D; Iemolo F; Pizzo F; Sciarrino S; Licata G; Pinto A
    Clin Biochem; 2012 Nov; 45(16-17):1525-30. PubMed ID: 22820434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invariant exon skipping in the human alpha-galactosidase A pre-mRNA: Ag+1 to t substitution in a 5'-splice site causing Fabry disease.
    Sakuraba H; Eng CM; Desnick RJ; Bishop DF
    Genomics; 1992 Apr; 12(4):643-50. PubMed ID: 1315304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.